During the corresponding time, Iqvia Holdings Inc recorded a revenue increase by 8.41 % year on year, sequentially revenue fell by -4.88 %. While revenue at the Iqvia Holdings Inc 's corporate clients
Iqvia Holdings Inc's Comment on Sales, Marketing and Customers
The company provides advanced analytics, technology, and domain expertise to stakeholders in the healthcare and life sciences sectors globally. Its key market segments include outsourced research and development, with an estimated addressable opportunity of approximately $159 billion in clinical development spending in 2025, of which $75 billion is outsourced. Another segment is Real-World Evidence and connected health, with a total addressable market of about $90 billion in 2025, including a $35 billion life sciences market for Real-World Evidence. The company offers services such as clinical trial design, patient recruitment, real-world data analytics, clinical and commercial applications, and integrated solutions through IQVIA Connected Intelligence. It serves biopharmaceutical companies and the broader healthcare industry, supported by a global IT infrastructure and a workforce of approximately 93,000 employees worldwide.
IQVIA Leads the Way in Medical Affairs and Regulatory Operations, According to Independent Research Firm RESEARCH TRIANGLE PARK, N.C. - IQVIA (NYSE:IQV), a global healthcare intelligence company, has once again demonstrated its industry leadership by being recognized as a Leader in the Life Sciences Regulatory and Medical Affairs Operations PEAK Matrix Assessment 2024 survey conducted by Everest Group, a renowned independent research firm. The survey evaluates both market impact and delivery effectiveness, and IQVIA has emerged as a frontrunner in both areas.The recent report from Everest Group underscores IQVIA s unwavering commitment to innovation and its comprehensive portfolio of solutions that are revol...
Iqvia Holdings Inc’s Comment on Sales, Marketing and Customers
The company provides advanced analytics, technology, and domain expertise to stakeholders in the healthcare and life sciences sectors globally. Its key market segments include outsourced research and development, with an estimated addressable opportunity of approximately $159 billion in clinical development spending in 2025, of which $75 billion is outsourced. Another segment is Real-World Evidence and connected health, with a total addressable market of about $90 billion in 2025, including a $35 billion life sciences market for Real-World Evidence. The company offers services such as clinical trial design, patient recruitment, real-world data analytics, clinical and commercial applications, and integrated solutions through IQVIA Connected Intelligence. It serves biopharmaceutical companies and the broader healthcare industry, supported by a global IT infrastructure and a workforce of approximately 93,000 employees worldwide.
Sources:
Iqvia Holdings Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Iqvia Holdings Inc’s corporate clients.
For your research, we’ve provided 9 tables on Iqvia Holdings Inc corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
96.92 %